Avid Bioservices Inc (CDMO)

[biopharm]

GJH: interesting.... the talk about organs.. and transplants and drugs that make that all work better. One other company working on this is "Somahlution".

http://somahlution.com/management/

Our Somah technology was initially developed by a team of experienced transplant researchers and surgeons in the Cardiothoracic Surgery Department in the Veterans Affairs Boston Healthcare System and Harvard Medical School, led by Dr. Hemant Thatte, a renowned researcher in the field. Today, these technologies are enabling the development of SOMVC001, SOM102 and SOM103, our lead vascular conduit and organ preservation solution candidates. In addition we are also advancing multiple products for the preservation of a broad range of organs, tissues and cells.

Board of Directors

Vithalbhai Dhaduk, M.D.,Chairman
Amar Dhaduk
Darpan Dhaduk, M.D.
Satish Chandran, Ph.D.Chief Executive Officer
Catherine Pachuk, Ph.D.Chief Scientific Officer

Executive Management

Satish Chandran, Ph.D.,Chief Executive Officer
Tracy Goeken, MD.,Chief Medical Officer
Paul G. Lunn, Esq.,General & Intellectual Property Counsel
Catherine Pachuk, Ph.D.,Chief Scientific Officer
Rick Rayl, CPA,Chief Operating Officer

Strategic Advisory Board

Stephen Udem, MD, Ph.D., Chairman
Hemant Thatte, Ph.D.